Marinus Drug Patent Portfolio
Marinus owns 1 orange book drug protected by 9 US patents Given below is the list of Marinus's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10603308 | Methods and compositions for treatment of epileptic disorders | 10 Aug, 2037 | Active |
| US12144801 | Methods and compositions for treatment of epileptic disorders | 10 Aug, 2037 | Active |
| US7858609 | Solid ganaxolone formulations and methods for the making and use thereof | 28 Nov, 2026 | Active |
| US8022054 | Liquid ganaxolone formulations and methods for the making and use thereof | 28 Nov, 2026 | Active |
| US8318714 | Liquid ganaxolone formulations and methods for the making and use thereof | 28 Nov, 2026 | Active |
| US8367651 | Solid ganaxolone formulations and methods for the making and use thereof | 28 Nov, 2026 | Active |
| US8618087 | Solid ganaxolone formulations and methods for the making and use thereof | 28 Nov, 2026 | Active |
| US9029355 | Solid ganaxolone compositions and methods for the making and use thereof | 28 Nov, 2026 | Active |
| US9056116 | Liquid ganaxolone formulations and methods for the making and use thereof | 28 Nov, 2026 | Active |
Latest Legal Activities on Marinus's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Marinus.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 11 Jul, 2024 | US8367651 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 11 Apr, 2024 | US8318714 |
| Second letter to regulating agency to determine regulatory review period | 30 Sep, 2023 | US8318714 |
| Letter from FDA or Dept of Agriculture re PTE application | 28 Sep, 2023 | US8318714 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 10 Aug, 2023 | US10603308 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 28 Feb, 2023 | US8022054 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 24 Nov, 2022 | US9056116 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 07 Nov, 2022 | US9029355 |
| Letter re PTE application to FDA or Dept of Agriculture | 08 Jul, 2022 | US8318714 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 08 Jun, 2022 | US7858609 |
| Mail Pub Notice re 312 amendment | 31 May, 2022 | US8318714 |
|
Email Notification
Critical
| 31 May, 2022 | US8318714 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 27 May, 2022 | US7858609 |
| Post Issue Communication - Certificate of Correction Denied | 25 May, 2022 | US8318714 |
| POST ISSUE OTHER COMMUNICATION TO APPLICANT- CERTIFICATE OF CORRECTION | 25 May, 2022 | US8318714 |
Marinus's Family Patents
Marinus drugs have patent protection in a total of 15 countries. It's US patent count contributes only to 48.3% of its total global patent coverage. 2 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Marinus Drug List
Given below is the complete list of Marinus's drugs and the patents protecting them.
1. Ztalmy
Ztalmy is protected by 9 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10603308 | Methods and compositions for treatment of epileptic disorders |
10 Aug, 2037
(12 years from now)
| Active |
| US12144801 | Methods and compositions for treatment of epileptic disorders |
10 Aug, 2037
(12 years from now)
| Active |
| US7858609 | Solid ganaxolone formulations and methods for the making and use thereof |
28 Nov, 2026
(1 year, 6 months from now)
| Active |
| US8022054 | Liquid ganaxolone formulations and methods for the making and use thereof |
28 Nov, 2026
(1 year, 6 months from now)
| Active |
| US8318714 | Liquid ganaxolone formulations and methods for the making and use thereof |
28 Nov, 2026
(1 year, 6 months from now)
| Active |
| US8367651 | Solid ganaxolone formulations and methods for the making and use thereof |
28 Nov, 2026
(1 year, 6 months from now)
| Active |
| US8618087 | Solid ganaxolone formulations and methods for the making and use thereof |
28 Nov, 2026
(1 year, 6 months from now)
| Active |
| US9029355 | Solid ganaxolone compositions and methods for the making and use thereof |
28 Nov, 2026
(1 year, 6 months from now)
| Active |
| US9056116 | Liquid ganaxolone formulations and methods for the making and use thereof |
28 Nov, 2026
(1 year, 6 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ztalmy's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List